Stefano Caruso

[Stefano Caruso @Stecarus]

💥Thrilled to see our paper on Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma (cHCC-CCA) by @Caldera60373705 et al. finally out in @JHepatology.

A thread 🧵🪡 summarizing the main findings. 1/
@EASLnews

https://t.co/qV3sIYQ7bi

[Long Pan | 潘龙 @LongPan61162464]

Delighted to share my PhD work is now published in Nat Commun! 💯
We established a large HCC dataset including 529 tumors from 461 patients treated in Western countries, integrating WGS/WES, RNA-seq, DNA methylation and proteomics data.
https://t.co/PikMHtqIQC

[EU Interdisc. Society of AI for Cancer Research @ESAC_cancerAI]

One year after its launch, ESAC announces its 1st Annual Meeting.

📅 May 7–8, 2026
📍 Politecnico di Milano (Via Bonardi 9, 20133 Milan)
📢 Call for abstracts open until Feb 3, 2026

For details, visit the conference's website https://t.co/H579kgRGE0

Registrations opening soon

[Helena Linardou @ElinardouHelena]

🎓 New Webinar Series: Artificial Intelligence in Oncology
🤝 #HeCOG & @ESAC_cancerAI join forces for a monthly webinar series on how #AI is transforming #oncology.
🧠 Learn from leading experts, explore real-world clinical applications & the future of cancer care.
📅 Nov 4, 2025 | 17:00–20:00 EET
(🕓16:00–19:00 CET)
💻 Free registration 👉 https://t.co/c19BjUjD9u
📄 Program 👉 https://t.co/ckdofDmHnb
🚀 Join us and be part of this exciting initiative!
@ESAC_cancerAI @myESMO @I3Lung @oncodaily @PrelajArsela @katherlab @nkorfiatis
@jnkath @Vanja_Miskovic_ @HaniaPaverd
@protoss1986 @GhaffariNarmin @IsabellaWies @Stecarus @Caldera60373705
@mihaela_aldea @DanielTruhn @loic_verlingue @mireiacrispin @marinagarassino @RaqPerezLopez @HeSMO_X @myionio @OncoAlert @OncBrothers @Women4Oncology #AI #Oncology #AIInnovation #AIinHealthcare #AIinOncology

[Contra el Cáncer Investigación @contracancerINV]

📍 Cluj-Napoca, Romania. The European TANGERINE consortium, led by Dr. Víctor Moreno (@idibell_cat /@ICO_oncologia ), met to review progress on an AI tool that predicts immunotherapy response and toxicity in cancer patients.

🔬 A step forward in #PersonalizedMedicine, driven by global collaboration.

🔗 Read more: https://t.co/kBx6KtvM2T

#CancerResearch #AIinOncology #HorizonEurope
#TANGERINE #AECCtalent

[EASLnews @EASLnews]

At #LiverCancerSummit, Stefano Caruso introduced the transformative potential of spatial omics in liver cancer research. This emerging field offers unprecedented insights into tumor heterogeneity, microenvironment interactions, and high-resolution biomarker identification. With advancing technologies becoming faster and more accessible, the future of liver cancer diagnostics and treatment could soon involve spatial multi-omics, 3D profiling, and AI integration - potentially reshaping research discussions at future summits.

@rirmacias @FabioPiscaglia @AleksanderKrag @PinterMatthias

[Theo Hirsch @TZ_Hirsch]

Thank you @canceropole for the invitation to discuss spatial transcriptomics today in Paris! Very nice presentations and discussions!

[Jakob Nikolas Kather @jnkath]

This week, we hosted another summer school of medical AI at @tudresden_de @Medizin_TUD - led by @GhaffariNarmin 🤩 with dozens of participants from research teams in 🇮🇹🇫🇷🇷🇴🇩🇪🇺🇸 & plenty of discussions, memes & new research ideas 🌟 Funded by 🇪🇺 via https://t.co/zeoIvcscDR

[Stefano Caruso @Stecarus]

@DamsGREGOIRE Congrats Damien! Well deserved

[Precision-BTC-Network @PrecisionBTCnet]

Thank you once again to all our attendees for making the ENSCCA/Precision-BTC-Network Joint Meeting an unforgettable event! Your energy and contributions made it truly special. Thank you Krakow for hosting us! 🇵🇱 Looking forward to our next gathering! #ENSCCA #PrecisionBTCNet

[Francesco Amato, PhD @fr_amato]

Artificial intelligence for BTC management. Such brilliant talks regarding the application in BTC of this powerful technology. @PrecisionBTCnet @UCPHAndersenLab @Stecarus @hannah_muti #LucaViganó
#ensccaPrecisionBTCNetworkJointmeeting

[Precision-BTC-Network @PrecisionBTCnet]

Up next, Dr. Stefano Caruso @Stecarus dives into the integration of digital pathology and spatial genomics in liver cancer research and diagnostics at #PrecisionBTCNet #ENSCCA #Krakow2024. 🔬🇵🇱

[Jakob Nikolas Kather @jnkath]

What a fun session at @EASLedu @EASLnews #EASLcongress 2024 about "Research in the age of AI" in Milan 🇮🇹🇪🇺. Any biomedical researcher should be aware of current AI tools and develop a basic literacy. @tudresden_de @NCT_UCC_DD @NCT_HD @Medizin_TUD @uniklinik_hd

[Eric Trépo @etrepo]

🚀 It's AI Day #EASL2024 designed by our AI Task Force https://t.co/AfWOoxhfJq
📅
🧠 Research in the Era of AI 🕰️ 08:30 - 09:45
🌟 Studio: AI Liver Taskforce 🕰️ 12:30 - 13:00
🤖 AI in Clinical Care 🕰️ 17:15 - 18:15

 @EASLnews @aelsharkawy75 @AleksanderKrag @Caldera60373705

[Theo Hirsch @TZ_Hirsch]

Some personal news: I’ve secured a permanent research position at @Inserm so I'll be able to continue working with this happy bunch of the FunGeST team in the wonderful @CRCordeliers ! Stay tuned for scientific updates on the genomics of pediatric and adult liver cancer!

[Nature Communications @NatureComms]

Recently published: @jnkath @Caldera60373705 @Stecarus @GhaffariNarmin @QingheZeng use #DeepLearning to re-classify combined hepatocellular-cholangiocarcinomas using histopathology
#LiverCancer #CancerResearch @NatResCancer https://t.co/SyPCLStgrO

[Theo Hirsch @TZ_Hirsch]

Don’t hesitate to register for this free event later today!! We’ll discuss the challenges of Molecular Tumor Boards for Hepatocellular Carcinoma #LiverTwitter

[Jean-Charles Nault @NaultJc]

Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study - The Lancet Oncology by ⁦@Caldera60373705⁩ ! https://t.co/Rs38GR3pYE

[Stefano Caruso @Stecarus]

@TZ_Hirsch @LongPan61162464 @CRCordeliers 🤩

[Theo Hirsch @TZ_Hirsch]

If you want to know what is hidden behind @LongPan61162464, go see his poster at the #ILCA23 in Amsterdam!! @Stecarus @CRCordeliers

[Jean-Charles Nault @NaultJc]

Our last work "Molecular-based targeted therapies in patients with hepatocellular carcinoma and
hepato-cholangiocarcinoma refractory to atezolizumab/bevacizumab" was just released in journal of hepatology @JHepatology @CRCordeliers @Zucmanrossi

https://t.co/utcwou98yP